Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling from high-fat medium (HFM)-treated and growth medium (GM)-treated Sk-hep1 cells

ABSTRACT: Gene expression profiling from high-fat medium (HFM)-treated and growth medium (GM)-treated Sk-hep1 cells

PROVIDER: PRJNA432158 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Proteomic of M. hyorhinis-treated SK-HEP1 cells

Project description:Protein (30 μg) extracted from SK-Hep1 with or without M. hyorhinis infection

2022-10-10 | PXD037283 |

The effect of IL-37 in HCC cell line Sk-hep1

Project description:We performed whole microarray expressiong prolife of Sk-hep1 cells which could over-express IL-37. This project is to explore the effect of interleukin-37 on hepatocellular carcinoma(HCC) development. We transfected human HCC cell line Sk-hep1 with lentiviral vector encoding IL-37 or control. The successfully transfected cells were sorted by FACS and the cells were further cultured for 24 hours. The cells were harvested and send for microarray analysis.

2020-02-06 | GSE144728 | GEO

Gene expression profiling from high-fat medium (HFM)-treated and growth medium (GM)-treated Sk-hep1 cells

Project description:Non-alcoholic fatty liver disease (NAFLD) is a major problem in obese peoples and caused by unbalanced uptake of fatty acid. Novel drug identification is necessary to develop effective therapies. We combine LOPAC® and High-Content system to identify compounds significantly reducing intracellular lipid droplets after high fat medium (HFM) treatment. Among 1280 compounds, 5 show efficacy in lipid droplet reduction. To construct the underlying regulatory network, whole-genome transcriptomic, pathway, and connectivity map analysis are performed.

2018-01-31 | GSE109836 | GEO

Gene expression profile of TARDBP in hepatocellular carcinoma cell line (SK-Hep1)

Project description:TARDBP is TARDBP (TDP-43) is a DNA/RNA binding protein and was mutated in human amyotrophic lateral sclerosis (ALS). However, its function in human cancer has not been fully identified, yet.Thus, We carried out microarray to investigate the down-stream target genes of TARDBP after silencing TARDBP in liver cancer cell SK-Hep1. To identify the role of TARDBP in hepatocellular carcinoma cell line, we performed microarray after knocking down TARDBP in hepatocellular carcinoma cell line (3 siLuc, 3 siTARDBP)

2013-04-22 | E-GEOD-37640 | biostudies-arrayexpress

Gene expression profile of TARDBP in hepatocellular carcinoma cell line (SK-Hep1)

2013-04-22 | GSE37640 | GEO

RNA sequencing results of dipyridamole treatment in SLC29A2-expressing SK-hep1 cells

Project description:We observed an increasing trend of nuclear SLC29A2 expression associated with high histological de-differentiation grades, metastasis and poor patient prognosis by immunohistochemical analysis of HCC tumors. Treatments of dipyridamole to SLC29A2 expressing SK-hep1 cells reduced cell viability and cell migration. To examine the anticancer activities of dipyridamole, transcriptome analysis was performed to detect the modulations of oncogenic SLC29A2 and the downstream signaling pathways.

2020-10-23 | GSE139583 | GEO

mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq]

Project description:To functionally characterize the role of miR-17 family in HCC, lentiviral vector-based miR inhibitor TuD was used to inhibit miR-17 family of microRNAs in HepG2 and SK-Hep1 HCC cell lines

2017-06-01 | GSE93831 | GEO

Gene expression profile of YAP1, TEAD1 and KLF5 in hepatocellular carcinoma cell line (SK-Hep1)

Project description:Hippo signaling pathway is pivotally involved in human cancer. Among the Hippo components, YAP1 is highly active while function of MST1,2 and SAV1 was lost in liver cancer. Based on systematic analysis, we identified KLF5 as YAP1 binding partner in silico. To investigate KLF5 in liver cancer, we performed the gene expression microarray after knocked down YAP1, TEAD1 and KLF5 in SK-Hep1 cell line. To identify the role of YAP1, TEAD1 and KLF5 in hepatocellular carcinoma cell line, we performed microarray after knocking down YAP1, TEAD1 and KLF5 in hepatocellular carcinoma cell line (3 siLuc, 3 siYAP1, 3 siTEAD1, 3 siKLF5)

2013-12-31 | E-GEOD-32597 | biostudies-arrayexpress

Gene expression profile of YAP1, TEAD1 and KLF5 in hepatocellular carcinoma cell line (SK-Hep1)

2013-12-31 | GSE32597 | GEO

Expression profiling of Sk-Hep1 after PAI-1 silencing (RNAi)

Project description:Expression profiling of Sk-Hep1 after PAI-1 silencing (RNAi)

| PRJNA633599 | ENA